Sign in

CIK 0001850119 · <br>Emerging growth company

Century Therapeutics, Inc.

Sign in to watch
Ticker
IPSC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
842040295
Phone
215-981-4000
Business address
25 N 38TH STREET, 12TH FLOOR, PHILADELPHIA, PA
  1. 4 Open-market sale Chief Operations Officer sold 1,054 shares at $0.78 ($822)
  2. 4 Open-market sale SVP Finance & Operations sold 351 shares at $0.78 ($274)
  3. 4 Shares withheld for taxes President and CEO gave up 243,447 shares (to pay taxes)
  4. 4 Open-market sale Chief Operations Officer sold 1,033 shares at $1.23 ($1,267)
  5. 4 Open-market sale SVP Finance & Operations sold 283 shares at $1.23 ($347)
  6. 4 Grant or award Chief Finanical Officer acquired 60,148 shares (grant or award)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Grant or award Chief Scientific Officer acquired 74,376 shares (grant or award)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market buy Director bought 5,000 shares at $1.53 ($7,657)
  11. 4 Open-market sale Chief Operations Officer sold 1,073 shares at $1.83 ($1,960)
  12. 4 Open-market sale SVP Finance & Operations sold 289 shares at $1.83 ($528)
  13. 4 Planned sale See Remarks sold 586 shares at $2.50 ($1,465)
  14. 4 Planned sale See Remarks sold 1,800 shares at an average $2.52 ($4,529)
  15. 4 Planned sale See Remarks sold 5,000 shares at $2.84 ($14,179)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 5 of 10 · 188 filings